Gastric hyperplastic polyps coexisting with early gastric cancers, adenoma and neuroendocrine cell hyperplasia

Pol J Pathol. 2016 Mar;67(1):33-8. doi: 10.5114/pjp.2016.59474.

Abstract

Gastric hyperplastic polyps (GHP) constitute up to 93% of all benign epithelial polyps of the stomach. The average probability of malignant transformation in GHP is 0.6-22% in large series. The aim of the study was to present the coexistence of GHP with early gastric cancer (EGC), gastric adenoma (GA), neuroendocrine cell hyperplasia (NH) and well-differentiated neuroendocrine tumour (NET G1). Three cases were studied to reveal clinical data and morphological changes and to assess the relationship between GHP and accompanying gastric neoplastic lesions.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / pathology*
  • Aged
  • Cell Transformation, Neoplastic / pathology
  • Female
  • Humans
  • Hyperplasia / pathology
  • Male
  • Middle Aged
  • Neuroendocrine Cells / pathology*
  • Polyps / pathology*
  • Precancerous Conditions / pathology*
  • Stomach Neoplasms / pathology*